Andrew P. Han
Andrew Han covers breaking news for GenomeWeb. He tracks companies in the sequencing and diagnostic markets.
Researchers from Parse Biosciences and 10x Genomics and their collaborators discussed the ability of their platforms to process up to 1 million cells simultaneously.
A gapless human Y chromosome assembly is in the works and should be available in the next several months, NHGRI's Adam Phillippy said at the meeting.
The company's Tapestri platform can now run as few as 20,000 cells, and customers can order the same panels as featured in published papers.
Agilent allegedly tried to get Synthego to license patents related to CRISPR guide RNAs and threatened to escalate its response when Synthego did not do so.
Illumina blamed "manufacturing and supplier capacity constraints" for weekslong delays seen on orders for certain sequencing reagent kits.
The method could be used to sequence DNA molecules that fall between short and long reads, but where high throughput and single-base accuracy are required.
Illumina's NovaSeq, Oxford Nanopore's Flongle, and Genapsys were among the winners based on the results of the multiyear, multi-center NGS study.
The Arizona State University spinout is now working on manufacturing its sensors alongside nanopores small enough to sequence DNA.
The method, which can scan for interactions across a cell's entire proteome, is drawing interest from entities looking to both use and commercialize it.
Multiple studies are showing that long reads can deliver results where short reads can't, but many barriers remain on the road to the clinic.